Shane Cross, PharmD

Shane Cross, PharmD

  • Clinical Pharmacy Specialist-Antimicrobial Steward
  • Assistant Professor, The University of Tennessee Health Sciences Center, Department of Clinical Pharmacy and Translational Science

Board Certification(s)  

  • BCPS


  • PharmD - University of Missouri – Kansas City, Kansas City, Missouri

Post-Graduate Training  

  • Residency, Pediatric Pharmacotherapy, St. Jude Children’s Research Hospital, Memphis, TN
  • Fellowship, Clinical Pharmacokinetics, St. Jude Children’s Research Hospital, Memphis, TN

Focused Area of Practice

  • Antimicrobial Stewardship/Infectious Disease
  • Leukemia/Lymphoma
  • Hematopoietic Stem Cell Transplantation


  • St. Jude 5100 Club (Employee of the Quarter) – Clinical Division

Research Interests

  • Clinical Pharmacokinetics
  • Research Pharmacokinetics

St. Jude Committee Service

  • Institutional Review Board
  • Antimicrobial Utilization and Improvement Committee
  • Infection Prevention and Control Committee
  • Bone Marrow Transplant Quality Improvement Committee
  • Pharmaceutical Department Residency Committee
  • Pharmacogenetics Oversight Committee

Pharmacy Organizations/Committee Service

  • Pediatric Infectious Diseases Society 

Selected Publications

Millisor VE, Roberts JK, Sun Y, Tang L, Daryani VM, Gregornik D, Cross SJ, Ward D, Pauley JL, Molinelli A, Brennan RC, Stewart CF.  Derivation of new equations to estimate glomerular filtration rate in pediatric oncology patients.  Pediatr Nephrol.  2017 Jun 2. [Epub ahead of print]

Moriyama B, Obeng AO, Barbarino J, Penzak SR, Henning SA, Scott SA, Agúndez JA, Wingard JR, McLeod HL, Klein TE, Cross SJ, Caudle KE, Walsh TJ.  Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guideline for CYP2C19 and Voriconazole Therapy.  Clin Pharmacol Ther. 2016 Dec 16. [Epub ahead of print]

Duggin K, Tickle K, Norman G, Yang J, Wang C, Cross SJ, Gajjar A, Mandrell B.  Aprepitant reduces chemotherapy-induced vomiting in children and young adults with brain tumors. J Pediatr Oncol Nurs Sept-Oct;31(5):277-83, 2014. Epub 2014 Jun 27.

Srinivasan A, Panetta JC, Cross SJ, Pillai A, Triplett BM, Shook DR, Dallas MH, Hartford C, Sunkara A, Kang G, Jacobsen J, Choi J, Leung W. Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemia. Biol Blood Marrow Transplant Aug;20(8):1224-8, 2014. Epub 2014 Apr 23.

Bell GC, Crews KR, Wilkinson MR, Haidar CE, Hicks JK, Baker DK, Kornegay NM, Yang W, Cross SJ, Howard SC, Freimuth RR, Evans WE, Broeckel U, Relling MV, Hoffman JM. Development and use of active clinical decision support for preemptive pharmacogenomics. J Am Med Inform Assoc Feb;21:e93-e99, 2014. Epub 2013 Aug 26.

Bernardo VA, Cross SJ, Crews KR, Flynn PM, Hoffman JM, Knapp KM, Pauley JL, Molinelli AR, Greene WL. Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer. Ann Pharmacother Jul-Aug;47(7-8):976-83, 2013.  Epub 2013 Jun 4.

Hicks JK, Crews KR, Hoffman JM, Kornegay NM, Wilkinson MR, Lorier R, Stoddard A, Yang W, Smith C, Fernandez CA,  Cross SJ, Haidar C, Baker BK, Howard SC, Evans WE, Broeckel U, Relling MV. A Clinician-Driven Automated System for Integration of Pharmacogenetic Interpretations Into an Electronic Medical Record. Clin Pharmacol Ther Nov;92(5):563-6, 2012. Epub 2012 Sept 19.

Srinivasan A, Kasow KA, Cross S, Parrish M, Wang C, Srivastava DK, Cai X, Panetta JC, Leung W. Phase I study of the tolerability and pharmacokinetics of palifermin in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant Aug;18(8):1309-14, 2012. Epub 2012 Apr 25.

Crews KR, Cross SJ, McCormick JN, Baker DK, Molinelli AR, Mullins R, Relling MV, Hoffman JM. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm Jan 15;68(2):143-50, 2011.

Cross SJ, Rodman JH, Lindsey JC, Robbins BL, Rose CH, Yuen GJ, D'angelo LJ. Abacavir and Metabolite Pharmacokinetics in HIV-1-infected Children and Adolescents. J Acquir Immune Defic Syndr May 1;51(1):54-9, 2009.

Sleasman JW, Robbins BL, Cross SJ, Lindsey JC, Kraimer JM, Heckman BE, Sprenger HL, Tustin NB, Rose CH, Poston PA, Neal EF, Pakes GE, Nikanjam M, Capparelli EV. Abacavir Pharmacokinetics During Chronic Therapy in HIV-1-Infected Adolescents and Young Adults. Clin Pharmacol Ther Apr;85(4):394-401, 2009. Epub 2008 Dec 31.

Last update: January 2018